Follow Us TR

News Details

AnPac Bio Announces Positive Results from a Multi-Year Lung Cancer Prognosis and Recurrence Clinical Study

About AnPac Bio-Medical Science Co., Ltd.
  • NASDAQ: $ANPC
  • Notified: $5.02
  • 07:30 EDT

Price Chart